期刊文献+

急性乙醇中毒患者纳洛酮应用剂量的相关影响因素分析 被引量:1

Naloxone dose in the treatment of acute alcohol poisoning and its affected factors
原文传递
导出
摘要 目的研究救治急性乙醇中毒患者的纳络酮剂量范围,并分析不同临床特点患者的用量范围。方法 2012年1月至2013年12月收治284例急性乙醇中毒患者,先给予患者0.8 mg纳洛酮静脉注射,然后予0.2 ml/h静脉滴注直至患者清醒。计算患者的清醒时间及总纳洛酮用量,分析不同性别、年龄、体重、饮酒量、中毒时间长短的纳洛酮用量差异,并采用多重线性回归方法分析纳洛酮用量与以上因素的相关关系。结果 284例患者的清醒时间为(4.22±1.64)h。纳洛酮用量为(1.61±0.73)mg。女性[(1.83±0.52)mg]、肥胖[(1.85±0.42)mg]及大量饮酒[(1.94±0.41)mg]患者的纳洛酮用量明显高于男性[(1.52±0.45)mg]、正常体重[(1.54±0.39)mg]和少量饮酒者[(1.33±0.32)mg](P均﹤0.01)。多重线性回归分析显示急性乙醇中毒患者的纳洛酮用量与性别、体重、饮酒量相关(P均<0.01)。结论急性乙醇中毒患者的纳洛酮剂量与患者的性别、体重、饮酒量有关,对于女性、肥胖及大量饮酒的患者可以采用较高剂量的纳洛酮治疗。 Objective To study naloxone dose range in the treatment of patients with acute alcohol intoxica- tion and analyze the different dosage in patients with different clinical characteristics. Methods The data of 284 patients with acute alcohol poisoning admitted between January 2012 and December 2013 were collected. 0. 8 mg of naloxone was given by intravenous injecting first, and then 0.2 ml/h of naloxone was given by intravenous infusion until patient awaked. The time from beginning medieat/on to awaking and the total amount of naloxone were calculated. The variances of naloxone dosage in different gender, age, body weight, alcohol consumption and intoxication du- ration were analyzed, and the correlation between the naloxone dosage and aforementioned factors was analyzed by multiple linear regression analysis. Results In 284 patients with acute alcohol intoxication, the mean waking time was (4.22 ± 1. 64) h, and the mean applied naloxone dosage was ( 1.61 ± 0. 73 ) rag. The naloxone dosages in female [(1.83 ± 0.52)mg] ,obesity [(1.85 ± 0.42)mg] and heavy drinking [(1.94 ± 0.41)mg] patients were re±spectively higher than those in male [ ( 1.52 ± 0.45 ) mg], normal body weight [ ( 1. 54 ± 0.39) mg ] and little drink- ing patients[ ( 1.33 ± 0.32 ) mg] ( all P 〈 0.01 ). Conclusions The naloxonc dosage in the treatment of acute alcohol intoxication is related to gender, body weight, alcohol consumption amount, and higher naloxone dose should be applied in the treatment for female, obesity and heavy drinking patients.
作者 罗志平
出处 《中国临床研究》 CAS 2014年第7期788-790,共3页 Chinese Journal of Clinical Research
基金 广东省梅州市医药卫生科研项目(2014-B-10)
关键词 乙醇中毒 急性 纳洛酮 剂量 相关性 Acute alcohol poisoning Naloxone Dose Correlation analysis
  • 引文网络
  • 相关文献

参考文献12

  • 1Wand GS,Weerts EM, Kuwabaru H, et al. The relationship between naloxone-induced cortisol and mu opioid receptor availability in me- solimbic structures is disrupted in alcohol dependent subjects [ J]. Alcohol,2012,46(6) :511 -517.
  • 2Miranda-Morales RS, Molina JC, Spear NE, et al. Naloxone attenua- tion of ethanol-reinforced operant responding in infant rats in a re- exposure paradigm [ J ]. Psychupharmacology, 2012,219 ( 1 ) : 235 -246.
  • 3Wu Y, Lousberg EL, Moldenhauer LM,et al. Inhibiting the TLR4 -MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice [ J ]. Br J Pharmaeol, 2012,165 ( 5 ) : 1319 - 1329.
  • 4杨小冶,黄永阳.不同剂量纳洛酮治疗急性酒精中毒昏迷的疗效观察[J].吉林医学,2009,30(17):1989-1990. 被引量:7
  • 5张世福.不同首次剂量纳洛酮在治疗急性重度乙醇中毒中的疗效比较[J].吉林医学,2012,33(35):7691-7691. 被引量:1
  • 6丁康,周建中.超大量与常规剂量纳洛酮治疗重症乙醇中毒的疗效比较[J].现代中西医结合杂志,2012,21(1):41-42. 被引量:6
  • 7Lovallo WR, King AC, Farag NH, et al. Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcohol- ism:studies from the Oklahoma Family Health Patterns Project [ J ]. Psychaneuroendocrinology,2012,37 ( 12 ) : 1922 - 1928.
  • 8Perry CJ, McNally GP. Naloxone prevents the rapid reacquisition but not acquisition of alcohol seeking [ J ]. Behav Neurosci, 2012,126 (4) :599 -604.
  • 9Ray LA, Barr CS, Blendy JA, et al. The role of the Asn4OAsp poly- morphism of the mu opioid receptor gene ( OPRMI ) on alcoholism etiology and treatment:a critical review[ J]. Alcohol Clin Exp Res, 2012,36(3) :385 -394.
  • 10Reid LD. Opioid Antagonists and Ethanol's Ability to Reinforce In- take of Alcoholic Beverages: Preclinical Studies[M]//Dean R,Bil- sky E J, Negus SS. Opiate Receptors and Antagonists: From Bench to Clinic. Totowa : Humana Press Inc ,2009:335 - 369.

二级参考文献9

共引文献11

同被引文献25

引证文献1

二级引证文献2

;
使用帮助 返回顶部